Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
出版年份 2010 全文链接
标题
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 60, Issue 2, Pages 197-206
出版商
Springer Nature
发表日期
2010-10-25
DOI
10.1007/s00262-010-0927-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- From the Editors
- (2010) T. Gansler et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas
- (2009) L Vardouli et al. CANCER GENE THERAPY
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
- (2009) T. Nicholaou et al. CLINICAL CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- CD4+CD25+CD127low/− regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
- (2009) Li-Song Shen et al. CLINICAL IMMUNOLOGY
- Promising novel immunotherapies and combinations for prostate cancer
- (2009) Philip M Arlen et al. Future Oncology
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients
- (2009) Bülent Karagöz et al. MEDICAL ONCOLOGY
- CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
- (2008) B. Kavanagh et al. BLOOD
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
- (2008) M. A. Morse et al. BLOOD
- Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
- (2008) J. Yokokawa et al. CLINICAL CANCER RESEARCH
- CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab?
- (2008) C. Menard et al. CLINICAL CANCER RESEARCH
- Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing
- (2008) K. S. Sfanos et al. CLINICAL CANCER RESEARCH
- Increased circulating regulatory T cells (CD4+CD25+CD127−) contribute to lymphocyte anergy in septic shock patients
- (2008) Fabienne Venet et al. INTENSIVE CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation